HKDC1 and metabolic dysfunction-associated steatohepatitis: Moreover, mice that developed LC with NASH had >100-fold higher HKDC1 mRNA expression in the liver tissue (non-tumor regions) than controls (Fig. 1D; left panel), with corresponding enhanced HKDC1 protein expression (Fig. 1D; right panel).